A capsaicinoid‑based soft drug, AG1529, for attenuating TRPV1‑mediated histaminergic and infammatory sensory neuron excitability See

Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders See

A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration See

Bradykinin Induces TRPV1 Exocytotic Recruitment in Peptidergic Nociceptors See

Neurotrophins, endocannabinoids and thermo-transient receptor potential: a threesome in pain signalling See

αCGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors See

Tumor Necrosis Factor–Interleukin-17 Interplay Induces S100A8, Interleukin-1 , and Matrix Metalloproteinases, and Drives Irreversible Cartilage Destruction In Murine Arthritis See

The CO-releasing molecule CORM-3 protects against articular degradation in the K/BxN serum transfer arthritis model See

Design and Validation of Novel Potential Antiperspirant Peptides Blocking M3-Gαq Sweat Signaling Cascade See